A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
about
sameAs
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarctionEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Bubble-induced platelet aggregation in a rat model of decompression sickness.Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.Lysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillationNew Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications.Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED scoreUsefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation.Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.Platelet Reactivity Is Independent of Left Atrial Wall Deformation in Patients with Atrial Fibrillation.Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillationEffect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot StudyCardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.Clopidogrel hydrogen sulphate for atrial fibrillation.The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study.Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation.Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.Elevated platelet microparticle levels in valvular atrial fibrillation.Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.Pharmacologic strategies for the prevention of stroke in patients with atrial fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.
P2860
Q28168338-CAF51B7C-991E-4830-B185-20C1D58AC22BQ30375302-03D1A50A-8AF9-4A28-923C-0664227B417BQ33444057-335A0EBD-27C9-4993-9A3A-AB70FDDDAD8BQ33712583-07BD245F-45EB-49E1-A21D-1212913DD309Q34378059-2FD44B9C-E41F-4AD4-8EC6-121F3C66F49FQ34532327-3F83F040-7074-4453-A6B2-5E9291F922DDQ35605552-45DD6B68-C245-477F-BA35-EBC2C6B2C2A5Q35962795-4635EB5D-3238-4B72-BD8F-A3F95C87F3BBQ36146288-8B9CADD4-284E-4B0D-9C56-1A1AC61964A8Q36216795-F65C088C-0EA9-4EC7-8147-4055D2AB4028Q36741772-757AC07F-DA23-41F2-AE6E-67CC80479870Q36784683-57E646D3-08B8-4553-91E1-75799391E42CQ36999944-1FE5A67B-D8D5-4E18-B335-6D28F4B3CC37Q37464600-691AA03F-A2CD-469F-A4D9-C8090CA7F941Q37887815-ACDE86C0-3086-49F8-849E-45A3359459CDQ38931729-09F617BA-FDD4-487F-A7FB-6B0D0913A589Q39182923-C134A076-DDD1-4D4C-BC4A-EF0FD6B705EDQ39209674-8B2974A9-63FC-477F-938A-CAED9D2D7E65Q45154419-7F550036-4F55-4408-93AB-5279D22B4E4BQ46090464-6A44FF7C-4A78-4543-8BDC-088A915E87FFQ46779569-C40D14D7-225A-4659-8748-89F075FE0856Q52586010-99BDFC4D-9D98-456C-BC09-63A1C3325BA3Q53150344-0B756CBF-5627-4FE1-B7E8-031040401B52Q55638585-5F023918-564C-4A96-8BB0-DDEEE133AC24
P2860
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A study of platelet activation ...... ects of antithrombotic therapy
@ast
A study of platelet activation ...... ects of antithrombotic therapy
@en
A study of platelet activation ...... ects of antithrombotic therapy
@nl
type
label
A study of platelet activation ...... ects of antithrombotic therapy
@ast
A study of platelet activation ...... ects of antithrombotic therapy
@en
A study of platelet activation ...... ects of antithrombotic therapy
@nl
prefLabel
A study of platelet activation ...... ects of antithrombotic therapy
@ast
A study of platelet activation ...... ects of antithrombotic therapy
@en
A study of platelet activation ...... ects of antithrombotic therapy
@nl
P2093
P50
P3181
P356
P1476
A study of platelet activation ...... ects of antithrombotic therapy
@en
P2093
P304
P3181
P356
10.1053/EUHJ.2002.3259
P407
P577
2002-11-01T00:00:00Z